Cargando…
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
Availability of organs is a limiting factor for lung transplantation, leading to substantial mortality rates on the wait list. Use of organs from donors with transmissible viral infections, such as hepatitis C virus (HCV), would increase organ donation, but these organs are generally not offered for...
Autores principales: | Galasso, Marcos, Feld, Jordan J., Watanabe, Yui, Pipkin, Mauricio, Summers, Cara, Ali, Aadil, Qaqish, Robert, Chen, Manyin, Ribeiro, Rafaela V. P., Ramadan, Khaled, Pires, Layla, Bagnato, Vanderlei S., Kurachi, Cristina, Cherepanov, Vera, Moonen, Gray, Gazzalle, Anajara, Waddell, Thomas K., Liu, Mingyao, Keshavjee, Shaf, Wilson, Brian C., Humar, Atul, Cypel, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351537/ https://www.ncbi.nlm.nih.gov/pubmed/30696822 http://dx.doi.org/10.1038/s41467-018-08261-z |
Ejemplares similares
-
Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS
por: Qaqish, Robert, et al.
Publicado: (2020) -
Increased Arginase Expression and Decreased Nitric Oxide in Pig Donor Lungs after Normothermic Ex Vivo Lung Perfusion
por: Tavasoli, Farshad, et al.
Publicado: (2020) -
Successful 3-day lung preservation using a cyclic normothermic ex vivo lung perfusion strategy
por: Ali, Aadil, et al.
Publicado: (2022) -
A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide
por: Michaelsen, Vinicius S., et al.
Publicado: (2021) -
When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)